Mar 30, 2012 | Laboratory Pathology
Now in its fifth year, Indiana’s CDHP now covers 90% of eligible state employees
Many pathologists and clinical laboratory managers are carefully watching for evidence that new healthcare delivery models can deliver improved patient outcomes at a lower cost. Now comes evidence that a consumer-directed health plan (CDHP) for Indiana state employees—that incentivizes consumers to manage their healthcare dollars more carefully—is saving money for both employees and the state.
According to a story in the Centre Daily Times (CDT), state officials in Indiana claim that the state’s CDHP has reduced the state’s overall health benefit costs and met with high subscriber satisfaction.
Governor Mitch Daniels and other Indiana officials claim that, since introducing the CDHP in 2006, the Hoosier state’s overall health benefit costs are down by more than 10%, with only 2% of subscribers switching back to a traditional plan, the CDT reporter wrote.
(more…)
Sep 26, 2011 | Uncategorized
Clinical and anatomic pathology laboratories may soon find next-generation DNA sequencing reliable and affordable
Swift advances in whole human genome sequencing may bring clinical applications to pathology on a much faster timeline than expected.
One impressive example of the fast pace of technology improvements is the Ion Torrent, which is a semiconductor-based DNA sequencer now capable of sequencing 100 million base pairs. That is ten times the sequencer’s capacity when it was launched just last December!
It was August of last year when Life Technologies (NASDAQ: LIFE) in Carlsbad, California, paid $375 million to acquire Ion Torrent Systems, a start-up with operations in Guilford, Connecticut, and South San Francisco. If Ion Torrent achieves certain technical milestones through 2012, it will earn another $350 million.
(more…)
Jul 1, 2011 | Laboratory Pathology
Proposed repeal rule was published in yesterday’s Federal Register
Yesterday, pathologists and clinical laboratory managers got an early Fourth of July present. That’s because the federal Centers for Medicare and Medicaid Services (CMS) published the proposed rule that repeals the requirement that paper requisitions for medical laboratory tests must have the physician’s signature.
This rule had been mandated by the 2011 Medicare Physician Fee Schedule Rule that was to take effect on January 1, 2011. In response to the negative response to this rule from important sectors of healthcare, including laboratory medicine professionals, hospital groups, and physician associations, as well as both Houses of Congress, CMS deferred implementation of the rule for the first 90 days of 2011. (See Dark Daily, “Good News for Clinical Laboratories as CMS Delays Physician’s Signature Requirement, December 22, 2010.”
(more…)
Jul 19, 2010 | Laboratory Hiring & Human Resources, Laboratory Management and Operations, Laboratory Pathology
Plans are to centralize all cervical cancer screening in just two Alberta medical laboratories
Ongoing efforts to further consolidate clinical laboratory testing in the Canadian Province of Alberta caused local pathologists earlier this year to go on record to specifically oppose a proposed consolidation of Pap Smear testing. Over the past 15 years, the Alberta government has never been timid in its efforts to use consolidation of clinical pathology laboratory testing as a way to achieve cost savings.
During the past winter, more than 30 pathologists in Alberta signed letters to Health Minister Gene Zwozdesky to protest the consolidation of all the province’s Pap Smear testing into just two clinical laboratories—one in Edmonton and one in Calgary. As a result of the government’s decision to consolidate this medical laboratory testing service, cytology laboratories in Lethbridge, Medicine Hat, Red Deer, and the University of Alberta Hospital would no longer perform Pap smear testing.
(more…)
May 26, 2010 | Laboratory News, Laboratory Pathology
First-mover medical laboratory marketers are engaging customers on web sites such as MySpace.com and YouTube.com
Social networking is a radically new concept that innovative clinical laboratories, pathology practices, and in vitro diagnostic (IVD) manufacturers are beginning to use as a new marketing channel to their customers and prospects. The first wave of pathology and clinical laboratories are establishing a presence on such popular social networking web sites as Facebook.com, MySpace.com, YouTube.com, and Twitter.com.
Clinical laboratory marketing experts are using social networking sites like these to push products and services and to interact with customers. These sites allow pathologists, clinical labs, in vitro diagnostics manufacturers, and other companies to promote themselves and to tout the performance of their services and products by connecting lab directors and pathologists to physician clients and consumers in ways that were not possible years ago.
(more…)
